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Abstract: Micronuclei, comet and chromosome alterations assays are the most widely used 
biomarkers for determining the genotoxic damage in a population exposed to genotoxic 
chemicals. While chromosome alterations are an excellent biomarker to detect short- and 
long-term genotoxic effects, the comet assay only measures early biological effects, and 
furthermore it is unknown whether nuclear abnormalies, such as those measured in the 
micronucleus test, remain detectable long-term after an acute exposure. In our previous 
study, an increase in structural chromosome alterations in fishermen involved in the clean-up 
of the Prestige oil spill, two years after acute exposure, was detected. The aim of this study 
is to investigate whether, in lymphocytes from peripheral blood, the nuclear abnormalies 
(micronucleus, nucleoplasmic bridges and nuclear buds) have a similar sensitivity to the 
chromosome damage analysis for genotoxic detection two years after oil exposure in the 
same non-smoker individuals and in the same peripheral blood extraction. No significant 
differences in nuclear abnormalies frequencies between exposed and non-exposed individuals 
were found (p > 0.05). However, chromosome damage, in the same individuals, was higher 
in exposed vs. non-exposed individuals, especially for chromosome lesions (p < 0.05). These 
findings, despite the small sample size, suggest that nuclear abnormalities are probably  
less-successful biomarkers than are chromosome alterations to evaluate genotoxic effects 
two or more years after an exposure to oil. Due to the great advantage of micronucleus 
automatic determination, which allows for a rapid study of hundreds of individuals exposed 
to genotoxic chemical exposure, further studies are needed to confirm whether this assay is 
or is not useful in long-term genotoxic studies after the toxic agent is no longer present. 
Keywords: micronucleus test; chromosome damage; nuclear abnormities; chromosome 
alterations; oil exposure; genotoxicity; Prestige catastrophe 
 
1. Introduction 
Significant marine oil spills, approximately namely 14 accidents involving large oil tankers, have 
occurred in regions with a high population density in the last five decades [1,2]. When a sizeable spill 
occurs, there are usually a large number of individuals, in general local inhabitants, who collaborate in 
clean-up tasks to minimize the negative ecological and economic impact. So, for example, more than 
300,000 people were involved in the clean-up activities after the wreck of the oil tanker Prestige, in 
November 2002. Although there are relatively few studies which have focused on the repercussions of 
acute oil exposure for human health, there is growing concern about the chemical exposure that clean-up 
activities involve and their potential health effects. Direct contact with oil or its vapors can cause skin 
rash and eye redness, and prolonged exposure can cause nausea, dizziness, headache, respiratory 
problems and psychiatric disorders [1,2]. Moreover, due to certain volatile organic oil compounds, in 
particular benzene, being carcinogenic in humans [3], it is very important to determine if exposure to oil 
during clean-up tasks is associated with genotoxic effects in the short- (less than 12 months) and  
long-term (more than one year). So far, only a few human genotoxic studies in oil exposed populations 
have been published, most after the wreck of the Prestige [4–14]. In general, these studies revealed 
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increased genomic damage in exposed individuals during the clean-up tasks [4–11]. Nevertheless, only 
two research groups have carried out long-term genotoxic studies after oil exposure to the Prestige [12–15], 
with conflicting results. In one group, the authors described an increase of structural chromosome 
alterations in highly exposed vs. non-exposed individuals two and six years after exposure [12–14],  
this follow-up study reveal that chromosome damage persisted at least for the six years. Yet in another 
group, the study detected no genotoxic effects to be present seven years after exposure using other 
biomarkers (comet, micronucleus and T-cell receptor mutation assays) [15]. With the exception of  
T-cell receptor mutation assays, the sensibility of the two other biomarkers to detect long-term genotoxic 
effects has not been tested. 
The micronucleus test, comet assay and chromosome alterations have been the most common 
biomarkers to determine genetic damage in any population exposed occupationally or environmentally 
to genotoxic chemicals, e.g., oil exposure during clean-up tasks [4–18]. A micronucleus is the result of 
chromosome breakage (acentric fragment) and/or loss (whole chromosome) caused by errors in DNA 
repair or in chromosome segregations not included in the main nucleus that are surrounded individually 
by the nuclear membrane [19]. The micronucleus test is performed by cytokinesis-block assays using 
cytochalasin B, which allows to be analyzed other nuclear abnormalies, such as nucleoplasmic bridges 
and nuclear buds in binuclear cells. The nucleoplasmic bridges indicate the occurrence of reorganizations 
in which chromatids or chromosomes are pulled to opposite poles during anaphase, resulting in dicentric 
or ring chromosomes. The nuclear buds are characterized by having the same morphology as  
a micronucleus, but they remain connected to the main nucleus and represent the process of elimination 
of amplified DNA or of the DNA repair complex and possibly excess chromosomes from aneuploid 
cells. Recently, it has been described that nucleoplasmic bridges and nuclear buds are also useful 
biomarkers for monitoring genetic damage by detecting and quantifying DNA damage and chromosome 
instability [20–23]. The comet biomarker is based on how a genotoxic agent will produce DNA-strand 
breaks and measures the extent of DNA migration in electrophoresis [24] and has been frequently used 
because it is a fast and easy method to assess DNA breaks with excellent sensitivity. Finally, chromosome 
alterations are any change in the normal structure or number of chromosomes. In general, their analyses 
for genotoxic studies include lesions (gaps and breaks of one or both chromatids) and structural 
alterations (such as acentric fragments, deletions, translocations, dicentrics, rings, marker chromosomes) 
resulting in direct DNA breakage, errors in synthesis or repair of DNA, and have been widely used 
biomarkers since the 1970s [16,23,24]. Although comet and nuclear anomaly assays are probably less 
resolute and less informative than is metaphasic chromosome analysis, in the last several years both tests 
have been used extensively in studies to evaluate genotoxic damage in large populations of exposed 
individuals because they are much easier and faster [19]. 
The evaluation of chromosome alterations requires cell cultures, while the evaluation of nuclear 
abnormalities requires cells in division but comet assay can be performed without the use of proliferative 
cells. For a long time, peripheral lymphocyte cultures have been the most widely employed in human 
genotoxic studies, however the introduction of nuclear abnormalities and comet assays as biomarkers 
allows for the use of alternative cell types, such as epithelial cells [25,26]. Epithelial cells can be used 
as early-effect biomarkers; nasal epithelial cells are replaced approximately once every 30 days and 
buccal epithelial cells one every 10–14 days [26] vs. peripheral blood lymphocytes, which serve as  
long-effect biomarkers and are renewed around every 4 to 6 years [27]. The great advantage of using, 
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for example, buccal epithelial cells vs. lymphocytes is the easy and minimally invasive collection of 
samples, but the most important disadvantages are the discrepancies which come from using blood cells. 
In contrast to the body of research regarding the use of different biomarkers to determine the 
genotoxic effect when the agent is present, there is scarce information to determine long-term effects 
after an acute exposure, with chromosome damage being the biomarker most frequently used. Given that 
the comet test indicates early biological effects [28,29]; it is probably not an ideal biomarker for long-term 
studies after acute genotoxic exposure. Although the usefulness of nuclear abnormalies, especially the 
micronucleus test, for short-term genotoxic studies is unquestionable, its sensibility for long-term 
studies, when the toxic agent is missing, has not been demonstrated yet. The main objective of this study 
is to determine whether nuclear abnormalies remain useful biomarkers for detecting genotoxic effects 
two years after Prestige oil exposure, comparing their results with those detected by chromosome 
alterations analyses. 
2. Material and Methods 
2.1. Study Population 
The present study was performed on randomly selected subsamples of individuals included in  
a previous genotoxic study [12,13]. It was conducted using peripheral blood lymphocytes from individuals 
who had participated in clean-up activities of the Prestige oil spill. Only fishermen were included in our 
study in order to minimize other occupational sources of exposure that could act as confounders.  
A questionnaire survey including information about participation in clean-up tasks, health problems, 
lifestyle, history of cancer, medication, smoking status, fertility, age, and gender among 6780 fishermen 
one year after exposure was performed [30]. The selection criteria of individuals highly exposed and 
non-exposed to the oil was established from this information, described previously [30]. In brief, exposed 
local fishermen who participated for at least 15 days in clean-up activities of the Prestige oil spill,  
for four or more hours per day, during the first two months (when exposure presumably was greatest) 
were included as highly-exposed subjects for the study. Non-exposed individuals were selected from 
fishermen who had not participated in clean-up tasks for reasons other than those related to health.  
All exposed and non-exposed individuals were non-smokers (current smokers and ex-smokers were 
excluded), fertile and without a history of cancer, A new questionnaire and face-to-face interview, in 
order to verify the answers, was performed in a mobile unit that traveled to the participants’ villages on 
the same day in which the samples were obtained two years after the spill. In the present work, a total of 
20 exposed and 20 non-exposed individuals were studied, randomly selected from 91 exposed and  
46 non-exposed individuals in which chromosome damage was analyzed [12,13]. Figure 1 shows the 
flow diagram of the study. The exposed group consisted of 9 men and 11 women with an average age of 
48.2 years (ranging from 32.2 to 62.2; SEM = 1.9). The non-exposed group consisted of 3 men and  
17 women with an average age of 53.1 years (ranging from 36.6 to 58.8; SEM = 1.3). No significant 
relationship between sex and group was found according to Fisher’s exact test (p = 0.0824).  
The difference in age was found to be statistically significant both by Student’s t-test and Wilcoxon sum 
of ranks. In principle, as a higher age could be associated with a higher propensity to present genotoxic 
abnormalities, the distribution of age in the sample could make it more difficult to statistically prove  
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the association between abnormalities and oil exposure. Thus, because there are more older individuals 
included in the non-exposed group, age distribution should not favor the hypothesis of finding 
abnormalities in the exposed group. The collection, transport and processing of the samples were 
performed between 22 and 27 months after the Prestige disaster. 
The project was approved by the Ethics Committee on Clinical Research of Galicia, and all participants 
provided written, informed consent. 
 
Figure 1. Flow diagram of the study. a Detailed description in Zock et al. [30]; b Detailed 
description in Rodriguez-Trigo et al. [12]; and c Detailed description in Monyarch et al. [13]. 
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2.2. Cytogenetic Analysis 
Peripheral blood was obtained in same extraction and later cultured at 37 °C in supplemented  
RPMI-1640 medium (GIBCO Invitrogen Cell Culture, Invitrogen; Carlsbad, CA, USA) according to 
standard procedures. 
For the cytokinesis-block nuclear abnormalies test, peripheral blood was cultured, in duplicate,  
for 44 h and then cytochalasin-B was added to a final concentration of 6 µg/mL. Cells were harvested 
by centrifugation after 72 h of culture and submitted to middle-hypotonic treatment with 0.075 mM KCl 
at 4 °C. Cells were fixed in Carnoy (methanol-acetic acid 3:1 v/v), placed on dry slides, and stained with 
Leishman according to standard procedures. The micronucleus, nucleoplasmic bridges and nuclear buds 
in binucleated cells were identified according to the criteria of the HUMN project [31] and were 
evaluated by scoring 1000 binucleated cells (500 from each culture) using an Olympus Bx60 microscope. 
The cytogenetic-block proliferation index was calculated by the relation between total of cells with 1, 2, 
3 and 4 micronuclei vs. total of cells analyzed. 
For chromosome breakage analyses involved in lesions and structural chromosome alterations, 
analyzed in published studies [12,13], peripheral blood was cultured, in duplicate, for 72 h and then 
harvested according to standard procedures. For chromosome lesions, a minimum at 100 metaphases 
were analyzed in each individual (50 from each culture). For structural chromosome alterations, at least 
25 banded metaphases were karyotyped in each participant. Criteria for cytogenetic evaluations were 
determined according to the International System for Human Cytogenetic Nomenclature [32]. 
2.3. Statistical Analysis 
A generalized estimating equation, GEE [12,13,33,34], was used for assessing the differences 
between the exposed and non-exposed groups for the micronucleus, nucleoplasmic bridges and nuclear 
buds, chromosome lesions and structural chromosome alterations. The GEE approach is an extension of 
generalized linear models designed to account for repeated, within-individual measurements.  
This method is particularly indicated for when the normality assumption is not reasonable, as happens, 
for instance, with discrete data. The GEE model was used instead of the classic Fisher exact test because 
the former takes into account the possible within-individual correlation, whereas the latter assumes that 
all observations are independent. Since several metaphases were analyzed per individual, the GEE model 
is more appropriate. Statistical significance was set at p < 0.05. Statistical analyses were carried out with 
SAS/STAT release 9.02 (SAS Institute Inc.; Cary, NC, USA). The GEE model was fitted using the 
REPEATED statement in the GENMOD procedure. The conservative Type 3 statistics score was used 
for the analysis of the effects in the model. Sex and age were found not to be statistically significant 
when included in the GEE model and therefore were removed from the analysis. 
3. Results 
A satisfactory cell growth in all cultures was observed. A total of 40,000 binucleate cells,  
4260 metaphases and 1100 karyotypes were analyzed in lymphocytes from exposed and non-exposed 
individuals respectively. All individuals had normal karyotypes (46,XX or 46,XY), except two cases, 
one with a polymorphic inversion of chromosome 9, inv(9)(p11q12), in an exposed individual (E14) and 
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another case with an increased length of the heterochromatin on the long arm of the Y chromosome, 
Yqh+, in a non-exposed individual (NE5). 
Cell growth in cytochalasin-B cultures (from exposed and non-exposed individuals) showed  
a cytogenetic-block proliferation index ranging between 30% and 60%. No significant statistical differences 
were found in the micronucleus or nuclear buds between exposed and non-exposed individuals (p = 0.4774 
and p = 0.2356, respectively), and nucleoplasmic bridges were marginally influential (p = 0.08). 
Chromosome lesions were higher in exposed rather than in non-exposed individuals (p = 0.0231),  
but structural chromosome alterations were only marginally (p = 0.0972). Marker chromosomes, unbalanced 
translocations and deletions were the structural chromosome alterations most frequently observed in 
both groups of individuals, and ring chromosomes and acentric fragments were only detected in exposed 
individuals. Numerical chromosome alterations (such as trisomies and monosomies) were excluded in 
these analyses because they can be attributed to the failure of the chromosome spread due to non-specific 
techniques having been applied to remaining cell membranes. 
Table 1 and Figure 2 show the nuclear abnormalies (micronucleus, nucleoplasmic bridges and nuclear 
buds) and chromosome damage (lesions and structural alterations) observed in the same individuals. 
Cytogenetic results for each individual are found in Table 2, showing high inter-individual genotoxic 
variability for all biomarkers analyzed (micronucleus, nucleoplasmic bridges, nuclear buds, 
chromosome lesions and structural chromosome alterations) in exposed and in non-exposed individuals. 
With the exception of the degree of oil exposure no other associations were found between genotoxic 
damage and the different factors analyzed in the present study. 
Table 1. Nuclear abnormalities and chromosome damage detected in same individuals exposed 
and non-exposed to oil. 
 Exposed Non-Exposed p-Value
Total Individuals, No. 20 20  
Total Binucleate Cells, No. 20.000 20.000  
Binucleated cells with micronucleus, No. (%) 457 (2.3) 514 (2.6) 0.4774 
1 micronucleus/cell, No. 399 450  
2 micronucleus/cell, No. 49 53  
3 micronucleus/cell, No. 9 11  
Nucleplasmic bridges, No. (%) 131 (0.65) 98 (0.49) 0.08 
Nuclear buds, No. (%) 106 (0.53) 68 (0.34) 0.2356 
Total Metaphases Analyzed (Uniform Stain), No. 2112 2.148   
Chromosome lesion, No. (%) 28 (1.3) 7 (0.3) 0.0231 
Total Metaphases Karyotyped (G-Banded), No. 537 563  
Structural chromosome alterations, No. (%) 36 (6.7) 16 (2.8) 0.0972 
Balanced, No. 1 3  
Unbalanced, No. 35 13  
 
J. Mar. Sci. Eng. 2015, 3 1341 
 
 
 
Figure 2. Genotoxic study using nuclear abnormalities and chromosome damage as biomarkers. Binuclear cells (left) showing: (A) one 
micronucleus, (B) nucleoplasmatic bridges, (C) nuclear buds, (D) two micronuclei; and Karyotype (right) with five marker chromosomes. 
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Table 2. Cytogenetic results in individuals exposed and non-exposed to oil. 
Type of 
individuals  
  Binucleate cells Chromosomal Lesions Structural Chromosomal Alteration 
Sex Age Cells  MN 
NBUP NPB Cells Lesions Karyotypes 
Structural 
Alterations 
Balanced 
Structural 
Alterations 
Unbalanced 
Structural 
Alterations 
Type of Structural Alteration 
   MN 0 1 2 ≥3 
Exposed                   
E1 woman 49.02 1000 29 971 27 2 0 4 7 100 1 27 5 0 5 
t(13;20)(q32;q12); t(9;?), t(10;18),mar; 
del(2)(q12) 
E2 man 54,01 1000 23 977 20 3 0 2 4 116 3 28 0 0 0  
E3 man 44,02 1000 21 979 19 2 0 5 3 105 6 29 1 0 1 ace 
E4 man 31,26 1000 17 983 16 1 0 7 1 105 2 25 2 0 2 ace,ace 
E5 woman 51,90 1000 25 975 22 3 0 11 8 103 0 26 0 0 0  
E6 man 35,92 1000 17 983 16 1 0 3 8 108 1 30 2 0 2 ace; add(12)(qter) 
E7 woman 49,62 1000 43 957 37 4 2 9 5 100 2 25 6 0 6 ace; t(4;16)(q13,p13.3); mar,mar,mar,mar 
E8 man 56,45 1000 43 957 37 4 2 19 6 102 1 29 0 0 0  
E9 woman 50,51 1000 11 989 9 2 0 16 14 100 6 26 1 0 1 ace 
E10 man 52,50 1000 9 991 8 1 0 2 17 102 1 26 0 0 0  
E11 woman 54,86 1000 32 968 24 8 0 4 5 110 0 25 0 0 0  
E12 woman 44,89 1000 37 963 30 5 2 12 2 112 0 26 1 0 1 mar 
E13 man 57,02 1000 18 982 18 0 0 9 3 100 1 31 1 1  t(13;11)(p25;q23) 
E14 woman 46,13 1000 18 982 16 1 1 7 3 104 1 26 1 0 1 mar 
E15 woman 62,17 1000 14 986 11 3 0 4 3 103 0 25 3 0 3 t(7;10); r, r 
E16 woman 48,99 1000 10 990 8 2 0 1 1 112 0 25 1 0 1 t(X;4)(q21;p16) 
E17 woman 58,37 1000 8 992 8 0 0 1 3 105 0 27 1 0 1 del(7)(q33) 
E18 woman 36,90 1000 31 969 26 3 2 4 4 112 0 30 1 0 1 mar 
E19 man 52,98 1000 38 962 34 4 0 5 6 106 2 26 1 0 1 del(7)(p15) 
E20 man 54,94 1000 13 987 13 0 0 6 3 107 1 25 9 0 9 mar,mar; ace, ace; mar, mar,mar,mar,mar 
   20000 457 19543 399 49 9 131 106 2112 28 537 36 1 35  
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Table 2. Cont. 
Non-
Exposed 
                 
NE1 woman 54,33 1000 22 978 19 3 0 3 0 103 0 25 0 0 0  
NE2 woman 50,60 1000 22 978 17 4 1 0 0 100 3 34 0 0 0  
NE3 woman 57,52 1000 13 987 10 2 1 4 2 105 0 25 4 0 4 mar,mar,mar,mar 
NE4 woman 57,19 1000 14 986 13 1 0 16 0 101 1 25 1 0 1 del(1)(q21) 
NE5 man 58,78 1000 22 978 19 2 1 1 8 108 0 26 3 0 3 del(2)(q21); del(1)(q23), mar 
NE6 woman 57,61 1000 59 941 52 6 1 2 6 100 0 25 1 1 0 t(13;14)(q14,q32) 
NE7 woman 36,56 1000 5 995 3 2 0 5 7 107 0 25 1 0 1 del(1)(q32) 
NE8 woman 53,22 1000 30 970 26 3 1 1 7 110 0 33 1 0 1 mar 
NE9 woman 58,58 1000 50 950 43 6 1 5 1 113 0 43 0 0 0  
NE10 woman 56,00 1000 26 974 22 1 3 9 1 107 0 26 0 0 0  
NE11 woman 56,85 1000 10 990 10 0 0 3 4 120 1 25 1 0 1 mar 
NE12 woman 46,36 1000 38 962 32 5 1 9 5 130 0 26 0 0 0  
NE13 woman 55,82 1000 12 988 10 2 0 2 6 101 0 25 0 0 0  
NE14 woman 45,84 1000 26 974 24 2 0 8 4 108 2 25 0 0 0  
NE15 man 48,56 1000 41 959 33 7 1 8 3 107 0 25 0 0 0  
NE16 woman 55,54 1000 23 977 23 0 0 5 2 102 0 26 0 0 0  
NE17 woman 58,62 1000 36 964 32 4 0 8 4 112 0 26 1 0 1 del(9)(q21) 
NE18 man 57,15 1000 38 962 37 1 0 6 3 105 0 43 0 0 0  
NE19 woman 49,98 1000 18 982 16 2 0 3 1 108 0 26 2 1 1 t(8;13)((q24.1;q31); t(2;5) 
NE20 woman 46,31 1000 9 991 9 0 0 0 4 101 0 29 1 1 0 t(3;8)(q27;q13) 
   20000 514 19486 450 53 11 98 68 2148 7 563 16 3 13  
Abbreviations: ace: acentric fragment; add: additional material of unknown origin; del: deletion; mar: marker chromosome; p: short arm; q: long arm; qter: terminal long arm; t: translocation; MN: micronuclei; 
NBUP: nucleoplasmic bridges; NPB: nuclear buds. Commas indicate the beginning of new metaphase. 
 
J. Mar. Sci. Eng. 2015, 3 1344 
 
 
4. Discussion 
Toxic agents can induce complex changes in the genome, and to-date there is no single biomarker  
to detect all types of these alterations, probably due to different molecular mechanisms being  
involved [29,35,36]. It is therefore probable that not all genotoxic biomarkers are equally useful for  
long-term evaluation after exposure. 
To date, very few long-term genotoxic studies after an accidental oil exposure have been previously 
published [12–15]. In all of these studies only individuals highly exposed to oil were included, yet the 
findings obtained were not coincident. While an increase of structural chromosome alterations in 
exposed individuals two and six years after exposure was observed [12–14], no genotoxic effects using 
other biomarkers (comet, micronucleus and T-cell receptor mutation assays) after seven years were 
detected [15]. The T-cell receptor mutation assay, used in Laffon’s study [15], is an excellent biomarker 
for long-term studies because it provides information about the genotoxic effect which have occurred 
several months to several years after exposure [37]. However, the comet assay, also a successful 
biomarker employed by the authors, indicates early biological effects [28,29], so is probably not  
the most suitable test to evaluate long-term genotoxic effects. In relation to nuclear abnormalies, with 
the exception of Laffon et al. [15] and the present study, no other long-term genotoxic analyses have 
been performed, and in both studies no genotoxicity was detected two and seven years after oil exposure. 
Thus, we are not sure that this biomarker is still valid for long-term analysis. 
The main differences in the above referred studies [12–15] were the individuals included in the study, 
the time following oil exposure (two, six and seven years), and the biomarkers used (mainly chromosome 
damage vs. micronuclei and nuclear abnormalies). In order to minimize the dispersion of these factors, 
we have analyzed these same biomarkers two years after oil exposure in the same individuals in which 
chromosome alterations were observed. Our results showed no differences in micronuclei and nuclear 
abnormalies between those exposed and non-exposed to oil. Thus, if we had only used these biomarkers, 
our findings would have suggested that the genotoxic effect has disappeared two years after oil exposure, 
long before the seven years as described Laffon et al. [15] However, the present study shows an increase 
of chromosome damage in the same exposed individuals, in which no differences for nuclear abnormalies 
were found, indicating that genotoxic damage does persist two years after acute oil exposure. 
Additionally, an increase of chromosome damage in a high number of exposed individuals was 
previously reported two and six years after oil exposure [12–14]. Despite the very strict selection criteria 
for exposed individuals and the small sample size analyzed, the present findings, supported by those 
reported previously [12–15], suggest that micronuclei and nuclear abnormalies are probably less-successful 
biomarkers than are chromosome damage to evaluate genotoxic effect more than two years after acute 
oil exposure when the toxic agent is no longer present. Moreover, our results indicate that chromosome 
damage is more informative than micronuclei and nuclear abnormalies because acentric fragments 
(which corresponds to the origin of the micronucleus) and ring chromosomes (corresponding to 
nucleoplasmic bridges) were detected in exposed individuals two years after oil exposure. It is relevant 
to note that smokers were excluded in present study because an association between smoking and 
chromosome damage has been described [33,38]. Finally, due to the fact that the micronucleus test and 
other nuclear abnormalies can be detected automatically versus chromosome analysis, and moreover  
this test is much easier, faster and allows for analysis of a large number of cells and does not require as 
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much extensive personnel training, further studies are needed to confirm these preliminary results in 
larger samples. 
5. Conclusions 
To date, no information has been published regarding whether the micronucleus test remains suitable 
several years after the toxic agent is no longer present. For this reason, in the present study we evaluated 
the utility of nuclear abnormalies, including micronucleus test, to assess the genotoxic oil effect  
two years after the wreck of the Prestige comparing these results with those obtained from chromosome 
alterations analyses in the same non-smoker individuals and in the same peripheral blood extraction.  
Our results showed no differences in nuclear abnormalies between those exposed and non-exposed, 
however the chromosome damage was higher in exposed individuals. These features were compared 
with previous a report derived from long-term genotoxic studies after an accidental oil exposure.  
The main findings are: 
 nuclear abnormalies (micronucleus, nucleoplasmic bridges and nuclear buds) in binucleated cells 
may not detect genotoxic effects more than two years after acute oil exposure when the toxic agent 
is no longer present; 
 chromosome damage (chromosome lesion and structural chromosome alterations) in metaphases 
cells is a useful biomarker for assessing genotoxic effect two years after acute oil exposure using 
the same peripheral blood extraction in which nuclear abnormalies were analyzed; and 
 comparative study using nuclear abnormalies and chromosome damage analyses emphasizes  
the need to use appropriate biomarker for detection of genotoxic effect in individuals involved in 
toxic accidents. 
Despite the reduced number of individual analyzed, the present study suggests that micronuclei and 
nuclear abnormalies are probably less-successful biomarkers for the evaluation of long-term genotoxic 
oil effects when the toxic agent is no longer present. However, due to the fact that with the micronucleus 
test these and other nuclear abnormalies can be detected automatically, further studies are needed to 
confirm these preliminary results. 
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